Daniel J. Abdun-Nabi
2017
In 2017, Daniel J. Abdun-Nabi earned a total compensation of $3.7M as President and Chief Executive Officer at Emergent BioSolutions, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $806,208 |
|---|---|
| Option Awards | $847,072 |
| Salary | $819,029 |
| Stock Awards | $1,199,992 |
| Other | $8,983 |
| Total | $3,681,284 |
Abdun-Nabi received $1.2M in stock awards, accounting for 33% of the total pay in 2017.
Abdun-Nabi also received $806.2K in non-equity incentive plan, $847.1K in option awards, $819K in salary and $9K in other compensation.
Rankings
In 2017, Daniel J. Abdun-Nabi's compensation ranked 2,852nd out of 14,666 executives tracked by ExecPay. In other words, Abdun-Nabi earned more than 80.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,852 out of 14,666 | 81st |
Division Manufacturing | 977 out of 5,772 | 83rd |
Major group Chemicals And Allied Products | 261 out of 2,075 | 87th |
Industry group Drugs | 199 out of 1,731 | 89th |
Industry Pharmaceutical Preparations | 158 out of 1,333 | 88th |
Source: SEC filing on April 12, 2018.
Abdun-Nabi's colleagues
We found five more compensation records of executives who worked with Daniel J. Abdun-Nabi at Emergent BioSolutions in 2017.
2017
Fuad El-Hibri
Emergent BioSolutions
Chairman
2017
Robert Kramer
Emergent BioSolutions
Chief Financial Officer
2017
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
2017
Atul Saran
Emergent BioSolutions
General Counsel
2017
Adam Havey
Emergent BioSolutions